Status:
COMPLETED
Topical Antiperspirant for Hand-Foot Syndrome
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Palmar-plantar Erythrodysesthesia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The objectives of this study are to evaluate the effectiveness of an antiperspirant in preventing or attenuating the severity of palmer-plantar erythrodysesthesia associated with the Food and Drug Adm...
Eligibility Criteria
Inclusion
- Has not previously received a regimen that includes 5-fluorouracil
- \> 18 years old
- No known allergy or intolerance to Ban Unscented Roll-On Antiperspirant
Exclusion
- \< 18 years of age
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00213993
Start Date
May 1 2005
End Date
January 1 2007
Last Update
October 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792